Dr Edward Abadir is a haematologist at Royal Prince Alfred Hospital and the Chris O’Brien Lifehouse. He is a member of the cellular therapies team, specialising in allogeneic haematopoietic stem cell transplantation and CAR T therapies. He has an interest and oversees clinical quality outcomes and benchmarking for the cellular program at Royal Prince Alfred Hospital. In addition, he leads translational research projects in hematologic malignancies. His skills were developed as an NH&MRC postgraduate scholar where he completed his PhD at the University of Sydney in novel immunotherapies for acute myeloid leukaemia and stem cell transplantation.